![Peretz Partensky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peretz Partensky
Vorstandsvorsitzender bei ImmuneBridge, Inc.
Aktive Positionen von Peretz Partensky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pioneer Fund/NY/
![]() Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.09.2017 | - |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Vorstandsvorsitzender | 01.01.2018 | - |
Gründer | 01.01.2018 | - | |
Lemnos Labs, Inc.
![]() Lemnos Labs, Inc. Investment ManagersFinance Lemnos Labs Inc (Lemnos Labs) is a venture capital firm founded in 2011 by Jeremy Conrad and Helen Zelman Boniske. The firm is headquartered in San Francisco, California. | Private-Equity-Analyst | - | - |
Karriereverlauf von Peretz Partensky
Ehemalige bekannte Positionen von Peretz Partensky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sourcery Technologies, Inc.
![]() Sourcery Technologies, Inc. Packaged SoftwareTechnology Services Sourcery Technologies, Inc. develops a payments and commerce platform that focuses on the wholesale foodservice industry. Its features include invoice storage, analytics, online bill pay and high touch services. The company was founded by Na’ama Moran and Peretz Partensky in July 2012 and is headquartered in San Francisco, CA. | Gründer | 01.07.2012 | - |
Ausbildung von Peretz Partensky
University of California | Doctorate Degree |
University of Cambridge | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Founder | 2 |
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Finance | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Sourcery Technologies, Inc.
![]() Sourcery Technologies, Inc. Packaged SoftwareTechnology Services Sourcery Technologies, Inc. develops a payments and commerce platform that focuses on the wholesale foodservice industry. Its features include invoice storage, analytics, online bill pay and high touch services. The company was founded by Na’ama Moran and Peretz Partensky in July 2012 and is headquartered in San Francisco, CA. | Technology Services |
Pioneer Fund/NY/
![]() Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Health Technology |
Lemnos Labs, Inc.
![]() Lemnos Labs, Inc. Investment ManagersFinance Lemnos Labs Inc (Lemnos Labs) is a venture capital firm founded in 2011 by Jeremy Conrad and Helen Zelman Boniske. The firm is headquartered in San Francisco, California. | Finance |
- Börse
- Insiders
- Peretz Partensky
- Erfahrung